We return to the Dana Farber Cancer Institute this week as part of our "On the Road" series and interview the multitalented Dr. Geoffrey Shapiro. Dr Shapiro completed his medical training at Cornell University and received his PhD in 1987. His passions lie in early-phase drug development and clinical trials, with a specific flair for cell cycle and DNA repair inhibitor therapeutics. Dr. Shapiro provides an insightful take on drug development, current opportunities, challenges, the world of CDK inhibitors and the future landscape of trials, along with the role of Project Optimus (no, not Optimus Prime!)

The Kinghorn Cancer Centre and The Beverley Alt Scholarship proudly support this mini-series.

The Kinghorn Cancer Centre: https://tkcc.org.au/

Dana Farber Cancer Institute: https://www.dana-farber.org/

For more episodes, resources and blog posts, visit www.inquisitiveonc.com

Please find us on Twitter @InquisitiveOnc!

If you want us to look at a specific trial or subject, email us at [email protected]

Art courtesy of Taryn Silver

Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/

Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice. Minor edits have been made to the episode to improve sound quality and flow.

Hosted on Acast. See acast.com/privacy for more information.